Table 1. Early RA patient baseline demographics and associations with response to steroid/methotrexate therapy.

	Entire Cohort	NR	MOD/GOOD	NR vs. MOD/GOOD
	n = 73	n = 11	n = 31	p value
Gender (% women)	69	91	64	P = 0.03 (‡)
Age (median years)	51	59	48	P = 0.071 (φ)
Smoking (% ever smoked)	45.7	66	38.4	P = 0.245 (‡)
Smoking (% current smokers)	25.7	22.2	26.9	P = 1.0 (‡)
CCP titre (mean)	204	229	194	P = 0.539 (φ)
CCP positive (%)	86	90	84	P = 0.7448 (‡)
RF titre (mean)	145	192	127	P = 0.156 (φ)
RF positive (%)	80	80	80	P = 1.00 (‡)
DAS28ESR baseline	5.6	5.20	5.74	P = 0.44 (φ)
CD16 expression (mean MFI)	15.13	21.08	13.16	P = 0.0009 (φ)

A cohort of early RA patients (n = 73) were recruited for investigation. Baseline characteristics of the cohort is summarised in column [Entire cohort]. Patients with EULAR response data at week 14 post-initiation of therapy (n = 42) were furthermore split into non-responders [NR] or moderate/good responders [MOD/GOOD] and baseline characteristics in each subgroup analysed separately. Statistically significant differences between the two EULAR response subgroups [NR vs. MOD/GOOD] were examined. (‡) fishers statistical test (φ) mann-whitney U test.